1. Home
  2. TLYS vs SCYX Comparison

TLYS vs SCYX Comparison

Compare TLYS & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tilly's Inc.

TLYS

Tilly's Inc.

HOLD

Current Price

$4.30

Market Cap

43.3M

ML Signal

HOLD

Logo SCYNEXIS Inc.

SCYX

SCYNEXIS Inc.

HOLD

Current Price

$4.73

Market Cap

44.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLYS
SCYX
Founded
1982
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.3M
44.0M
IPO Year
2011
2014

Fundamental Metrics

Financial Performance
Metric
TLYS
SCYX
Price
$4.30
$4.73
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$2.00
$3.00
AVG Volume (30 Days)
255.3K
78.7K
Earning Date
06-03-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
62.34
61.36
EPS
N/A
N/A
Revenue
N/A
$257,000.00
Revenue This Year
$4.66
N/A
Revenue Next Year
$1.74
$608.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.14
$0.57
52 Week High
$5.90
$5.62

Technical Indicators

Market Signals
Indicator
TLYS
SCYX
Relative Strength Index (RSI) 48.20 71.79
Support Level $3.62 $0.67
Resistance Level $4.57 $5.62
Average True Range (ATR) 0.36 0.30
MACD -0.07 -0.05
Stochastic Oscillator 26.49 90.83

Price Performance

Historical Comparison
TLYS
SCYX

About TLYS Tilly's Inc.

Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion, and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: